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Vancomycin-resistant enterococci (VRE) pose an emerging health risk, but little is known about the precise
epidemiology of the genes coding for vancomycin resistance. To determine whether the bacterial flora of con-
sumer poultry serves as a gene reservoir, the level of contamination of poultry products with VRE was deter-
mined. VRE were genotyped by pulsed-field gel electrophoresis (PFGE), and transposon structure mapping was
done by PCR. The vanX-vanY intergenic regions of several strains were further analyzed by sequencing. A total
of 242 of 305 (79%) poultry products were found to be contaminated with VRE. Of these VRE, 142 (59%) were
high-level-vancomycin-resistant Enterococcus faecium strains (VREF). PFGE revealed extensive VREF hetero-
geneity. Two genotypes were found nationwide on multiple occasions: type A (22 of 142 VREF [15%]) and type
B (14 of 142 VREF [10%]). No PFGE-deduced genetic overlap was found when VREF from humans were com-
pared with VREF from poultry. Two vanA transposon types were identified among poultry strains. In 59 of 142
(42%) of the poultry VREF, the size of the intergenic region between vanX and vanY was ;1,300 bp. This trans-
poson type was not found in human VREF. In contrast, all human strains and 83 of 142 (58%) of the poultry
VREF contained an intergenic region 543 bp in size. Sequencing of this 543-bp intergenic vanX-vanY region
demonstrated full sequence conservation. Though preliminary, these data suggest that dissemination of the re-
sistance genes carried on transposable elements may be of greater importance than clonal dissemination of resis-
tant strains. This observation is important for developing strategies to control the spread of glycopeptide resistance.
Colonization and infection by vancomycin-resistant entero-
cocci (VRE) have been reported for hospitalized patients and
for communities of various European countries, including
France (7, 31), the United Kingdom (11, 24), Belgium (22),
and The Netherlands (21). VRE pose a health risk, especially
in patients with severe underlying disease or immunosuppres-
sion. In the United States, the prevalence of VRE in hospital-
ized patients is rising and hospital outbreaks of clonally related
VRE have been described (9, 13, 18, 32). In contrast, the
prevalence of VRE in hospitals in Europe remains low and a
high degree of heterogeneity is observed among the VRE
strains. Bates et al. (5) suggested that European VRE might be
more widely disseminated than originally supposed. Further-
more, there are cases on record of the isolation of VRE from
animals and from environmental sources in many European
countries (5, 16, 29, 37). Paradoxically, VRE have not yet been
recovered from animal and environmental sources in the
United States (14, 36). The spread of vancomycin resistance is
of considerable concern. Noble et al. (33) reported in vitro
conjugative transfer of high-level vancomycin resistance from
Enterococcus faecalis to Staphylococcus aureus. In response, the
Hospital Infection Control Practices Advisory Committee in
collaboration with the Centers for Disease Control and Pre-
vention has developed recommendations to prevent the spread
of VRE (23). Others have proposed control measures in case
vancomycin-resistant S. aureus eventually arises (20). Recently,
scientists from Japan and the United States have reported that
S. aureus intermediately resistant to vancomycin has been iso-
lated from patients (10, 15), although this resistance has been
shown not to be mediated by the vanA, vanB, or vanC gene
(30).
The increasing use of antimicrobial agents in human medi-
cine and as animal growth promoters has been related to the
emergence of VRE (32). In Europe, antimicrobial agents are
widely used as feed additives for growth promotion in animal
husbandry (38). Avoparcin is a glycopeptide antibiotic used for
this purpose in poultry, and it appears to be associated with the
emergence of resistance to glycopeptides in general (4, 5, 25).
Enterococci belong to the natural intestinal flora of poultry. It
is, thus, not unlikely that transmission of VRE occurs through
human contact with poultry meat contaminated with resistant
bacteria. However, such a route of transmission of VRE from
poultry to humans has not been unequivocally documented so
far. We determined the level of contamination of poultry prod-
ucts with VRE. The VRE isolated from poultry products were
compared with a collection of VRE isolated from humans (21)
with regard to their overall genome structures and eventual
polymorphism in Tn1546, the transposon encoding high-level
glycopeptide resistance.
(Parts of this study were presented at the 37th Interscience
Conference on Antimicrobial Agents and Chemotherapy, which
was held in Toronto, Ontario, Canada, from 28 September to
1 October 1997 [21a].)
MATERIALS AND METHODS
Poultry products. A total of 305 poultry products (whole chickens, chicken
legs, chicken breasts, or other chicken parts) from either butchers, supermarkets,
shop poulterers, or market poulterers were collected by Dutch food inspection
services in the following cities: Den Haag, Maastricht, Alkmaar, Amsterdam,
Nijmegen, Rotterdam, Leeuwarden, Den Bosch, Goes, Zutphen, and Gronin-
gen, The Netherlands. The sampling period was from June until September 1996.
Isolation of VRE. Approximately 250 g of each poultry product was rinsed in
250 ml of buffered peptone water (Oxoid, Basingstoke, England). After over-
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night incubation of the buffered peptone water at 37°C, 1 ml was used to
inoculate 9 ml of Enterococcosel (BBL Microbiology Systems, Cockeysville,
Md.) supplemented with 6 mg of vancomycin per liter, which was then incubated
at 37°C for 24 to 48 h (25). All esculin-positive broth cultures were subcultured
on a kanamycin-esculin azide agar (Oxoid) (1). Presumptive identifications of the
Enterococcus spp. were made on the basis of colony morphology, results of Gram
staining, and the presence or absence of catalase and pyrase (Dryslide Pyrkit;
Difco Laboratories, Detroit, Mich.). Definitive identifications were made with
Accuprobe (GenProbe, San Diego, Calif.) and RAPID ID32 STREP (Bio-
Me´rieux, ’s Hertogenbosch, The Netherlands) test kits. The identification strips
were read after 5 and 24 h of incubation at 37°C. All strains containing the vanC1
gene were identified as Enterococcus gallinarum (27). Strains were stored at
280°C in medium containing 15% glycerol.
Additional enterococcal strains. Nineteen vancomycin-resistant Enterococcus
faecium strains (VREF), one vancomycin-resistant E. faecalis strain from hospi-
talized patients, and four VREF from nonhospitalized patients (21) were also
included in the study. All strains were highly resistant to both vancomycin and
teicoplanin and possessed the vanA gene (see below). E. faecium BM4147
(vanA), E. faecalis V583 (vanB), E. faecalis ATCC 19433, E. faecalis ATCC
29212, E. gallinarum BM4147 (vanC1), Enterococcus casseliflavus CCUG 18657
(vanC2), Streptococcus bovis ATCC 33317, and S. aureus ATCC 29213 were used
as reference strains.
Antimicrobial susceptibility tests. All enterococcal strains described above
were tested for vancomycin and teicoplanin resistance on a Mueller-Hinton agar
(Difco Laboratories) with E-test strips (AB BIODISK, Solna, Sweden) according
to the instructions of the manufacturer. All plates were incubated at 37°C and
read after 24 h.
DNA isolation. DNAs were isolated according to the method of Boom et al.
(8). In brief, all VRE strains were grown overnight at 37°C on brucella blood agar
plates. Ten colonies were mixed and suspended in 75 ml of TEG buffer (25 mM
Tris-HCl [pH 8.0], 10 mM EDTA, 50 mM glucose). A lysozyme solution (75 ml
of 10 mg/ml) was added, and this mixture was incubated for 1 h at 37°C.
Guanidine-hydrothiocyanate was added for cell lysis, and Celite (Janssen Phar-
maceuticals, Beerse, Belgium) was used for DNA binding. DNAs were washed
and finally eluted from Celite with 10 mM Tris-HCl (pH 8.0) by incubation at
56°C for 10 min. DNA concentrations were estimated by electrophoresis on 1%
TABLE 1. Nucleotide sequences of PCR primers
Test Primer paira Nucleotide sequence Size of PCR product (bp) Reference
Diagnostic PCR A1 59-GGGAAAACGACAATTGC-39 732 19
A2 59-GTACAATGCGGCCGTTA-39
B1 59-ATGGGAAGCCGATAGTC-39 635 19
B2 59-GATTTCGTTCCTCGACC-39
C1 59-GGTATCAAGGAAACCTC-39 822 19
C2 59-CTTCCGCCATCATAGCT-39
D1 59-CTCCTACGATTCTCTTG-39 439 19
D2 59-CGAGCAAGACCTTTAAG-39
Transposon mapping of
structural genes
VanR 59-AGCGATAAAATACTTATTGTGGA-39 645 28
VanR1 59-CGGATTATCAATGGTGTCGTT-39
VanS 59-AACGACTATTCCAAACTAGAAC-39 1,094 28
VanS1 59-GCTGGAAGCTCTACCCTAAA-39
VanH 59-ATCGGCATTACTGTTTATGGAT-39 943 28
VanH1 59-TCCTTTCAAAATCCAAACAGTTT-39
VanA 59-ATGAATAGAATAAAAGTTGCAATAC-39 1,029 28
VanA1 59-CCCCTTTAACGCTAATACGAT-39
VanY 59-ACTTAGGTTATGACTACGTTAAT-39 866 28
VanY1 59-CCTCCTTGAATTAGTATGTGTT-39
Orf1A 59-AGGGCGACATATGGTGTAACA-39 844 28
Orf1A1 59-GGGCGACGGTACAACATCTT-39
Orf1B 59-TGGTGGCTCCTTTTCCCAGTTC-39 1,007 28
Orf1B1 59-CGTCCTGCCGACTATGATTATTT-39
Orf1C 59-ACCGTTTTTGCAGTAAGTCTAAAT-39 1,066 28
Orf1C1 59-AAACGGGATTTAGAAATAGTTAAT-39
Orf2D 59-CCATTTCTGTATTTTCAATTTATTA-39 925 28
Orf2D1 59-CATAGTTATCACCCTTTCACATA-39
Orf2E 59-TTGCGGAAAATCGGTTATATTC-39 540 28
Orf2E1 59-AGCCCTAGATACATTAGTAATT-39
Transposon mapping of
intergenic regions
VanXY1 59-AATAGCTATTTTGATTTCCCCGTTA-39 543 6
VanXY2 59-TCCTGAGAAAACAGTGCTTCATTAA-39
VanSH1 59-TAGGGTAGAGCTTCCAGCGATTGC-39 311 6
VanSH2 59-CTCATCCTGCTCACATCCATAAACA-39
VanYZ1 59-GTTTCCCGGATCAACACATACTA-39 336 6
VanYZ2 59-CCCAGTAGCAGTAAATGGAGTCA-39
a Primers D1 and D2 are specific for the vanC2 gene. Orf1 is transposase, and Orf2 is resolvase.
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agarose gels (Hispanagar; Sphaero Q, Leiden, The Netherlands) containing
ethidium bromide in the presence of known quantities of lambda DNA as
references.
vanA, vanB, vanC1, and vanC2 PCR. Diagnostic PCR assays targeting the
various resistance genes were performed as described by Dutka-Malen et al. (19).
Approximately 10 to 100 ng (10 ml) of DNA was added to a PCR mixture (90 ml)
containing 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM MgCl2, 0.01% gelatin,
0.1% Triton X-100, 0.2 mM deoxyribonucleotide, and 1.2 U of Taq DNA poly-
merase (Sphaero Q). Four different primer couples (vanA, vanB, vanC1, and
vanC2 [see Table 1 for their DNA sequences]) were used in the assay (50 pmol
of each individual primer per reaction mixture). Amplification of DNA was
performed in a Biomed (Theres, Germany) thermocycler (model 60), with pre-
denaturation at 94°C for 2 min, followed by 30 cycles of 1 min at 94°C, 1 min at
54°C, and 1 min at 72°C. Amplicons were analyzed by electrophoresis on 1%
agarose gels (Hispanagar; Sphaero Q) containing ethidium bromide in the pres-
ence of a 100-bp DNA ladder (Gibco/BRL Life Technologies, Breda, The Neth-
erlands).
Transposon mapping by PCR.. To study heterogeneity of the VanA-encoding
transposon Tn1546, regions of potentially various lengths within the 10,801-bp
genetic element were studied by PCR (see Table 1 for primer sequences) (6, 28).
Trial experiments were performed for E. faecium and E. faecalis only, and
selection of a limited number of strains derived from either humans or poultry
was at random. PCR was performed as described above. Whenever differences
were detected in amplicon size, all additional E. faecalis and E. faecium strains
harboring the vanA gene were investigated.
PFGE. Ten colonies of an overnight culture, grown on a blood agar plate, were
mixed and suspended in 100 ml of EET buffer (100 mM Na2EDTA, 10 mM
EGTA, 10 mM Tris-HCl [pH 8.0]). This suspension was mixed with 100 ml of 1%
agarose (Incert Agarose; FMC, Rockland, Maine) and pipetted into small plug
molds. The cells suspended in the agarose plugs were lysed by incubation for 4 h
at 37°C in 1 ml of EET buffer containing 10 mg of lysozyme (Sigma, Instruche-
mie, Hilversum, The Netherlands). Next, the lysis solution was replaced by a 1-ml
EET buffer solution containing 1 mg of proteinase K (dissolved in 10 mM
NaCl–10 mM Tris-HCl [pH 8.0]–1% sodium dodecyl sulfate), which was then
incubated at 37°C for 16 h. The plugs were then washed six times (30 min each
time at room temperature) with T10E1 solution (10 mM Tris-HCl [pH 8.0], 1 mM
EDTA). Plugs were then stabilized twice for 30 min in 120 ml of 13 restriction
buffer solution, and approximately 40 U of the restriction enzyme SmaI (Boehr-
inger Mannheim, Mannheim, Germany) was added (incubation, 16 h at 25°C).
Electrophoresis (1% SeaKem agarose in 0.53 Tris-borate-EDTA) was per-
formed with a Bio-Rad contour-clamped homogeneous electric field mapper,
programmed in the auto-algorithm mode (block 1 run time, 8 h; switch time, 0.5
to 15 s; block 2 run time, 10 h; switch time, 15 to 30 s). The gels were stained with
ethidium bromide for 15 min and then destained in distilled water for 1 h before
being photographed under UV irradiation. The gels were inspected visually by
two different investigators. The pulsed-field gel electrophoresis (PFGE) patterns
were interpreted according to the guidelines of Tenover et al. (35). Isolates that
differed by one to three bands, consistent with a single differentiating genetic
event, were assigned a numbered subtype. Four or more band differences be-
tween two strains defined a different genotype. Genotypes determined for all
VREF isolated from chickens were compared with the PFGE characteristics
determined for VREF isolated from humans (21). Since the interpretative guide-
lines brought forward by Tenover et al. (35) are mainly for outbreak investiga-
tions, additional comparisons were performed. Data obtained from a randomly
selected group of 48 human- and poultry-derived VRE strains were studied in
more detail with Gelcompar software (Applied Maths, Gent, Belgium). The
PFGE patterns were scanned, and Dice analysis of peak positions was exe-
cuted. Unweighted pair group method using arithmetic averages was applied,
and the band-width tolerance was set critically at 1.2%.
Cloning and sequencing. For several strains, the amplicon derived from the
vanX-vanY intergenic region was cloned into plasmid pCR1 (Invitrogen, Leek,
The Netherlands) according to the manufacturer’s instructions. Clones contain-
ing a correctly sized insert were sequenced by using cycle sequencing technology
and a sequencing machine (model 373; Applied Biosystems Inc., Warrington,
United Kingdom). Raw sequence data were edited with 373 software (Applied
Biosystems Inc.).
RESULTS
VRE screening and antimicrobial susceptibility testing. Ta-
ble 2 summarizes all data gathered from the chicken speci-
mens. Apparently, 242 of 305 (79%) of the poultry samples
studied contained VRE. Out of these, 142 of 242 (59%) were
identified as VREF, which were found nationwide in all of the
participating centers. Thirty-six of 242 VRE strains (15%)
were identified as Enterococcus durans, 34 of 242 VRE strains
(14%) were identified as Enterococcus hirae, and 27 of 242
VRE strains (11%) were identified as E. gallinarum. E. faecalis
was found only three times (1%). For all VREF and vanco-
mycin-resistant E. faecalis strains, vancomycin MICs were
$256 mg/ml and teicoplanin MICs were 16 to $256 mg/ml,
which is indicative of the VanA phenotype. For vancomycin-
resistant E. gallinarum, vancomycin MICs were 8 to 16 mg/ml
and teicoplanin MICs were 1 to 3 mg/ml, the VanC pheno-
type. For the 70 strains classified as E. hirae or E. durans
MICs ranged from 16 to $256 mg/ml for vancomycin and from
2 to $256 mg/ml for teicoplanin. All those VRE, except van-
comycin-resistant E. gallinarum, harbored the vanA gene.
Strains containing the vanB or vanC2 gene were not found.
PFGE. One hundred forty-two E. faecium and three E. fae-
calis isolates were analyzed by PFGE. Most of the PFGE
banding patterns comprised 15 to 20 differently sized DNA
fragments. The data revealed that two of three E. faecalis
strains were genetically identical. Both strains originated from
the same geographical region. One hundred different geno-
types were identified in the group of VREF from poultry (for
some examples of PFGE banding patterns, see Fig. 1). How-
ever, two genotypes of E. faecium, type A (22 of 142 VREF)
and type B (14 of 142 VREF) (Fig. 2), were frequently found
by 10 of 11 of the food inspection services. These two geno-
types may represent Dutch epidemic VREF. When the poultry
VREF were compared with patient VREF, however, no over-
lap in visually defined genotypes was identified by PFGE on
TABLE 2. Numbers and percentages of VRE isolated from 305 poultry products by 11 health inspectorates in
The Netherlands in the period from June to September 1996
Region of the food
inspection department
in The Netherlands
No. of poultry
products
No. of poultry products
with VRE
No. (%) of poultry products with VRE of type:
E. faecium E. durans E. hirae E. gallinarum E. faecalis
Den Haag 34 18 15 (44) 3 (9)
Maastricht 40 33 16 (40) 4 (10) 6 (15) 7 (18)
Alkmaar 22 17 11 (50) 2 (9) 4 (18)
Amsterdam 47 35 19 (40) 4 (9) 5 (11) 5 (11) 2 (4)
Nijmegen 25 21 6 (24) 5 (20) 3 (12) 6 (24) 1 (4)
Rotterdam 17 12 5 (29) 4 (24) 3 (18)
Leeuwarden 32 20 13 (41) 2 (6) 4 (13) 1 (3)
Den Bosch 16 16 10 (63) 3 (19) 3 (19)
Goes 25 25 15 (60) 5 (20) 1 (4) 4 (16)
Zutphen 23 21 15 (65) 1 (4) 1 (4) 4 (17)
Groningen 24 24 17 (71) 3 (13) 4 (17)
Total (%)a 305 242 (79) 142 (47) 36 (12) 34 (11) 27 (9) 3 (1)
a Percentage of all 305 products.
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the basis of the criteria of Tenover et al. (35). This result was
essentially corroborated by Gelcompar analysis of the PFGE
data of 48 strains (Fig. 3). The figure shows that the highest
homology value between VRE from chicken and human is
60% (Goes 175 and Goes 178 versus 10a). Strains from the
different origins present in a clustered fashion. The epidemic
PFGE type A clusters at a high homology value (90% for Den
Bosch 155 to Goes 84). The type that was encountered among
humans relatively frequently (PFGE type M, described in ref-
erence 21) clustered as well. Finally, the figure shows that
chicken strains mingle with respect to geographic origin. A
total of 27 E. gallinarum strains could be identified on the basis
of the characteristic PFGE patterns displaying DNA fragments
smaller than 200 kb only (33).
Transposon mapping by PCR and sequencing. All PCR tests
for transposon mapping (Table 1) were done after a random
selection of five human and five poultry strains. PCR products
derived from structural Tn1546 genes for all human and poul-
try strains displayed identity in size after electrophoresis. The
same conclusion was reached when the intergenic vanS-vanH
and vanY-vanZ regions were amplified. However, the vanX-
vanY intergenic region of two poultry strains was ;1,300 bp in
size whereas the size of the PCR product in the other three
poultry strains and in the five human strains was approximately
540 bp. Subsequently, all VREF (142 poultry strains and 19
human strains) and all vancomycin-resistant E. faecalis strains
(three poultry strains and one human strain) were analyzed
with the vanX-vanY primer set. Both transposon types were
found in all participating centers, indicating equal distributions
of both of these transposon types. All human strains and 83 of
the 142 (58%) isolated poultry VRE strains contained an in-
tergenic region between vanX and vanY of approximately 540
bp. The 1,300-bp fragment was not found in human strains but
was found in 59 of the 142 (42%) poultry strains. Sequencing
of the 543-bp vanX-vanY intergenic regions of several VREF
from poultry as well as from humans demonstrated full se-
quence conservation. With the larger vanX-vanY fragment,
sequencing revealed the presence of IS1216V (40). This ele-
ment was identified previously in the same location (GenBank
accession no. L40841 [3]).
DISCUSSION
To the best of our knowledge this is the first systematic study
from continental Europe reporting a high prevalence of VRE
in consumer poultry at the retail level. Glycopeptide resistance
in enterococci isolated from living poultry has been associated
FIG. 1. PFGE patterns for 15 VREF isolated from poultry products collected
by the Dutch Food Inspection Services in Zutphen, The Netherlands. Molecular
lengths of the markers are indicated on the right.
FIG. 2. PFGE patterns of two epidemic genotypes of VREF. Lanes 1 to 4,
genotype A; lanes 5 to 8, genotype B. These genotypes were frequently found by
most of the food inspection services. Molecular lengths of the markers are
indicated on the right.
FIG. 3. Phylogenetic tree constructed on the basis of several PFGE types of
VREF derived from poultry products (originating from Den Bosch, Goes, and
Nijmegen, The Netherlands) and humans (20). The arrow indicates the highest
level of homology between VRE from poultry and humans (Goes 175 and Goes
178 versus 10a). Type A is the epidemic PFGE type among poultry clusters, and
strains have a high level of homology (Den Bosch 155 to Goes 84). Type M is the
type that was encountered among humans relatively frequently [20]).
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with the use of oral glycopeptide antibiotics in animal feed (4).
High-level resistance to glycopeptides has been shown to be
mediated by transferable plasmids that may harbor resistance
determinants to other drugs as well (26). Therefore, other
antimicrobial agents used as feed additives in veterinary med-
icine may also select for vancomycin resistance (33). Definition
of causal relationships requires detailed studies of the devel-
opment and spread of antibiotic resistance in poultry farms.
Comparison of resistant microorganisms derived from poultry
with those derived from humans may shed light on the role of
poultry as a possible reservoir of VRE.
We found that 70% of the poultry products at the retail level
were contaminated with VRE containing the vanA gene. The
majority of these VRE were E. faecium. A study from the
United Kingdom documented that 22 of 52 farm animals stud-
ied were colonized with VREF (5). In five uncooked chicken
specimens, VREF were also identified. All strains possessed
the vanA gene, which confers high-level resistance to vanco-
mycin. A study from Manchester, United Kingdom, revealed
that 90% of all uncooked chicken specimens contained VRE
that were genetically distinguishable (12). The strains differed
from clinical isolates but were capable of transferring the re-
sistance trait by conjugation experiments. Others showed that
vancomycin- and avoparcin-resistant E. faecium could be de-
tected in five of eight conventional Danish poultry farms (29).
On the other hand, among isolates from six ecology farms, no
glycopeptide resistance was observed. In Belgium, about 7% of
the animals investigated for VRE carriage (horses, dogs, pigs,
and chickens) were colonized with VREF (16). Interestingly,
VRE have so far not been recovered from animal sources in
the United States, which may be related to the fact that gly-
copeptides are not licensed for use as feed additives in animal
husbandry there (14, 35).
Twenty-seven of the poultry specimens contained E. gallina-
rum, a species which is rarely found in humans either as part of
gut flora or as clinical isolates. However, we have observed an
increase in the number of E. gallinarum strains isolated from
clinical material in our hospital since the introduction of a
screen agar containing 6 mg of vancomycin per liter (data not
shown). These observations suggest that additional research
into the relevance of E. gallinarum as a potential pathogen in
humans is needed. As enterococci are not routinely identified
to species level in many microbiology laboratories, E. gallina-
rum may well be underreported.
Two main routes of dissemination of vancomycin resistance
genes can be envisaged. First, resistant strains may spread in a
clonal fashion from one host to another. Second, the resistance
determinant may be passed on to other bacterial strains
through conjugation (2, 34).
Two major PFGE types of VRE have been identified among
poultry-derived strains. Since these types were identified by all
food inspection services, we are dealing with epidemic strains
and not a local outbreak. Neither of these two types nor any of
the other unique genotypes of VREF were found in fecal floras
of patients screened for VREF carriage in The Netherlands
(21). On the basis of these results, one could reject the hypoth-
esis that direct horizontal transmission of VRE from poultry to
humans via the food chain is a major transmission route, which
is corroborated by more extensive phylogenetic analysis of the
data (Fig. 3). Therefore, the answer to the question on the
origin of human VRE remains obscure. An alternative route
for introduction into humans may be by transmission of resis-
tance-encoding genes rather than by transmission of resistant
microorganisms. Several studies suggest that high-level resis-
tance to glycopeptides in enterococci isolated in Europe and
North America is mediated by transposons similar to Tn1546
(39). Mapping of the transposon as present in the poultry VRE
by PCR revealed the presence of two distinct vanA types.
Length variability was found in the vanX-vanY region. Among
VREF from poultry, many strains, including epidemic VREF,
carried an intergenic region between vanX and vanY of ap-
proximately 1,300 bp that was not encountered in the human
strains. The other poultry strains and all human strains had
identical vanX-vanY intergenic regions. This observation sug-
gests that, for as yet unknown reasons, some sort of species
barrier to the larger transposon type or limited conjugative
transfer may exist. More Dutch VRE from humans should be
investigated to confirm the data presented here. In contrast,
another transposon type that is prevalent in many poultry
strains and in all human strains may have spread from poultry
to humans via the food chain. As we studied only a limited
number of structural genes and intergenic regions, further de-
tailed analysis of the vanA gene cluster is in progress to confirm
that these transposons are related. The relationship between
the vanA clusters of VRE isolated from humans and poultry
was also determined by means of restriction fragment length
polymorphism (RFLP) analysis of the Tn1546-like element.
For this analysis, several human and poultry isolates were
studied in detail. All human isolates showed the same RFLP
type, as did some poultry isolates. The other isolates from
poultry contained an RFLP type which was clearly distinct
from the human RFLP type. (Work in collaboration with in-
vestigators at the National Institute of Public Health and the
Environment, Bilthoven, The Netherlands, is still in progress
[40].)
In conclusion, we report an extremely high prevalence of
VRE in consumer poultry in The Netherlands. A high preva-
lence of a deviant transposon type is found in poultry VRE
especially. Transmission of the resistance genes, rather than
clonal dissemination of resistant microorganisms, may be the
determining factor driving the spread of vancomycin resistance
from poultry to humans. If this suggestion can be substantiated
by additional research, this may have major implications for
the development of strategies to control the spread of glyco-
peptide resistance among bacterial species pathogenic to hu-
mans. More information is needed to further clarify and quan-
tify antibiotic resistance gene transfer from animals to humans.
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